✦ LIBER ✦

Efficacy and tolerability of intramuscular and oral ziprasidone in acute and agitated schizophrenic patients: An 8-week, open-label trial

✍ Scribed by C. Munizza; A. Mautone; F. Rappard; P. Tiradritti; F. Romeo

Book ID: 118438241
Publisher: Elsevier Science
Year: 2007
Tongue: French
Weight: 58 KB
Volume: 22
Category: Article
ISSN: 0924-9338
DOI: 10.1016/j.eurpsy.2007.01.438

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative efficacy and tolerability of

Comparative efficacy and tolerability of intramuscular/oral ziprasidone versus haloperidol: Clinical findings in Asian and foreign patients with acute schizophrenia

✍ B. Parsons; C. Siu; G. Cohen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 44 KB

Efficacy and tolerability of amlodipine

Efficacy and tolerability of amlodipine in patients with stable angina pectoris: an open-label, multicenter trial

✍ Hasan Kudat; Nevnihal Eren; Faruk Erzengin 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 600 KB

Efficacy and tolerability of mirtazapine

Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial

✍ J. E. Kim; S. J. Yoon; J. Kim; J. Y. Jung; H. S. Jeong; H. B. Cho; E. Shin; I. K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

The Efficacy and Safety of Switching to

The Efficacy and Safety of Switching to Ziprasidone from Olanzapine in Patients with Bipolar I Disorder: An 8-Week, Multicenter, Open-Label Study

✍ Lee, Hwang-Bin; Yoon, Bo-Hyun; Kwon, Young-Joon; Woo, Young Sup; Lee, Jung-Goo; 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 381 KB

Comparison of the efficacy and tolerabil

Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: An 8-week, multicenter, randomized, open-label, dose-titration study in korean patients with hypercholesterolemia

✍ Sang Hak Lee; Namsik Chung; Jun Kwan; Doo-Il Kim; Won Ho Kim; Chee Jeong Kim; Hy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 627 KB

Olanzapine monotherapy for acute depress

Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: results of an 8-week open label trial

✍ William V. Bobo; Richard A. Epstein; Richard C. Shelton 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract We evaluated the efficacy, tolerability, and safety of olanzapine monotherapy in 20 adult patients with bipolar I or II disorder, depressed phase. Patients received open‐label olanzapine monotherapy (mean modal dose, 15 mg/day) for 8 weeks. Assessments of psychopathology (Montgomery–Asb